Product Code: ETC406865 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United Kingdom (UK) animal model market is a significant sector within the life sciences industry, driven by research institutions, pharmaceutical companies, and contract research organizations. Animal models, including mice, rats, rabbits, and zebrafish, are widely used in preclinical research for drug development, disease modeling, and toxicology studies. The UK`s strong regulatory framework, advanced research infrastructure, and skilled workforce make it an attractive market for animal model suppliers. Increasing investments in research and development, particularly in areas such as personalized medicine and regenerative medicine, are further fueling the demand for animal models in the UK. However, ethical concerns surrounding the use of animals in research and the emergence of alternative technologies like in vitro models pose challenges to the growth of the market.
The UK Animal Model Market is witnessing several notable trends, including a growing demand for genetically modified animal models for research purposes, particularly in the fields of drug discovery and development. Researchers are increasingly utilizing animal models to study complex diseases and test potential treatments, driving the market growth. Additionally, there is a rising focus on ethical considerations and animal welfare standards, leading to the development of more sophisticated and humane animal models. The emergence of advanced technologies such as CRISPR/Cas9 gene editing has revolutionized the creation of genetically modified animal models, offering greater precision and efficiency. Overall, the UK Animal Model Market is evolving towards more specialized and ethical research practices to meet the demands of modern biomedical research.
In the United Kingdom (UK) Animal Model Market, challenges arise primarily from ethical considerations and regulatory constraints surrounding the use of animals in research. Public opinion and advocacy groups often raise concerns about animal welfare and the need for alternatives to animal testing, leading to increased scrutiny and pressure on researchers and companies utilizing animal models. Additionally, the regulatory landscape in the UK and the European Union requires stringent ethical approval processes and compliance with laws governing the use of animals in research, adding complexity and cost to conducting studies using animal models. Balancing the need for scientific advancement with ethical considerations and regulatory requirements poses a significant challenge for stakeholders in the UK Animal Model Market.
The United Kingdom Animal Model Market offers a range of investment opportunities across various sectors. The market for animal models in the UK is primarily driven by the pharmaceutical and biotechnology industries for drug development and research purposes. With increasing focus on personalized medicine and advancements in genetic engineering, there is a growing demand for specialized animal models that mimic human diseases. This presents opportunities for investment in companies involved in breeding and supplying genetically modified animals, as well as those offering services such as in vivo testing and preclinical research. Additionally, there is potential for growth in the development of animal models for non-pharmaceutical applications such as agricultural research and environmental testing, making the UK Animal Model Market a promising area for investors seeking exposure to the life sciences sector.
In the United Kingdom, the use of animals in research is governed by strict regulations enforced by the Animals (Scientific Procedures) Act 1986 (ASPA). This legislation requires that any research involving animals must be justified for scientific or medical purposes and comply with ethical principles. The UK Home Office is responsible for issuing licenses to research establishments and individuals conducting experiments on animals, ensuring that they meet stringent welfare standards. Additionally, the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) promotes the development and use of alternative methods to reduce the number of animals used in experiments. Overall, the UK government`s policies on animal research aim to balance scientific progress with animal welfare considerations in a highly regulated market.
The United Kingdom (UK) Animal Model Market is poised for steady growth in the coming years, driven by increasing research and development activities in pharmaceuticals, biotechnology, and academic institutions. The demand for animal models for studying diseases, drug development, and personalized medicine is expected to rise, leading to a higher adoption rate of advanced animal models such as genetically modified organisms. Additionally, the UK`s strong regulatory framework regarding the ethical use of animals in research ensures compliance and fosters innovation in the field. Technological advancements like CRISPR gene editing and the development of humanized models are also expected to propel market growth. Overall, the UK Animal Model Market is likely to experience sustained expansion, offering opportunities for market players to diversify and innovate their product offerings.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Animal Model Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Animal Model Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Animal Model Market - Industry Life Cycle |
3.4 United Kingdom (UK) Animal Model Market - Porter's Five Forces |
3.5 United Kingdom (UK) Animal Model Market Revenues & Volume Share, By Animal Type , 2021 & 2031F |
3.6 United Kingdom (UK) Animal Model Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Animal Model Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United Kingdom (UK) Animal Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased focus on research and development activities in the pharmaceutical and biotechnology industries |
4.2.2 Rising demand for personalized medicine and precision therapies |
4.2.3 Growing prevalence of chronic diseases necessitating animal models for research purposes |
4.3 Market Restraints |
4.3.1 Ethical concerns and regulatory restrictions related to the use of animals in research |
4.3.2 Availability of alternative technologies such as in vitro models and computational modeling |
4.3.3 High costs associated with the maintenance and use of animal models in research |
5 United Kingdom (UK) Animal Model Market Trends |
6 United Kingdom (UK) Animal Model Market, By Types |
6.1 United Kingdom (UK) Animal Model Market, By Animal Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Animal Model Market Revenues & Volume, By Animal Type , 2021 - 2031F |
6.1.3 United Kingdom (UK) Animal Model Market Revenues & Volume, By Rat, 2021 - 2031F |
6.1.4 United Kingdom (UK) Animal Model Market Revenues & Volume, By Mice, 2021 - 2031F |
6.1.5 United Kingdom (UK) Animal Model Market Revenues & Volume, By Guinea Pigs, 2021 - 2031F |
6.1.6 United Kingdom (UK) Animal Model Market Revenues & Volume, By Rabbits, 2021 - 2031F |
6.1.7 United Kingdom (UK) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 United Kingdom (UK) Animal Model Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Animal Model Market Revenues & Volume, By Drug Discovery & Development, 2021 - 2031F |
6.2.3 United Kingdom (UK) Animal Model Market Revenues & Volume, By Basic Research, 2021 - 2031F |
6.2.4 United Kingdom (UK) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 United Kingdom (UK) Animal Model Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Animal Model Market Revenues & Volume, By Pharma & Biotech Companies, 2021 - 2031F |
6.3.3 United Kingdom (UK) Animal Model Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.4 United Kingdom (UK) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F |
7 United Kingdom (UK) Animal Model Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Animal Model Market Export to Major Countries |
7.2 United Kingdom (UK) Animal Model Market Imports from Major Countries |
8 United Kingdom (UK) Animal Model Market Key Performance Indicators |
8.1 Number of new drug approvals based on research using animal models |
8.2 Investments in research and development in the pharmaceutical and biotechnology sectors |
8.3 Number of collaborations between research institutions and companies for animal model research |
9 United Kingdom (UK) Animal Model Market - Opportunity Assessment |
9.1 United Kingdom (UK) Animal Model Market Opportunity Assessment, By Animal Type , 2021 & 2031F |
9.2 United Kingdom (UK) Animal Model Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Animal Model Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United Kingdom (UK) Animal Model Market - Competitive Landscape |
10.1 United Kingdom (UK) Animal Model Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Animal Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |